Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes

Journal of the Chinese Medical Association

Volumn 66, Issue 5, 2003, Pages 263-270

  Chen, Kuo Jung ^a,b   Cheng, Chi Hung ^a,b   Wu, Ming Ju ^a,b   Chen, Cheng Hsu ^a,b   Shu, Kuo Hsiung ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Corticosteroid; Cyclophosphamide; IgA nephropathy

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; GLUCOCORTICOID;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT SELECTION; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL; DRUG COMBINATION; PATHOLOGY;

ADULT; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISOLONE; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 0142027530     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988;12:340-7.
2. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol 1986;26:174-80.
3. Kobayashi Y, Fuji K, Hiki Y, Tateno S, Jurokawa A, Kamiyama M. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuria cases. Nephron 1988; 48:12-7.
4. Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, et al. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 1987;36:56-64.
5. Walker RG, Yu SH, Owen JE, Kincaid-Smith P. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year perspective trial. Clin Nephrol 1990;34:103-7.
6. Goumenos D, Ahuja M, Shortland JR, Brown CB. Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 1995;10:1173-81.
7. Woo KT, Lee GS, Lau YK, Chiang GS, Lin CH. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later. Clin Nephrol 1991;36:60-6.
8. Churg J. Pathology of glomerulonephritis. Acad Med 1970; 46:761-8.
9. Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, et al. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy. Clin Nephrol 2000;53:1-9.
10. Kincaid-Smith P. Treatment of mesangial immunoglobulin A glomerulonephritis. Semin Nephrol 1999;19:66-172.
11. Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997;349:774.
12. Locatelli F, Pozzi C, Vecchio LD, Andrulli S, Pani A, Fongazzi G, et al. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomized multicentre trial. J Nephrol 1999;12:308-11.
13. Pozzi C, Locatelli F. The treatment of IgA nephropathy. J Nephrol 2000;13:78.
14. Shoji T, Nakanishi I, Suzuki A, Hayashi T, Togawa M, Okada N, et al. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis 2000;35:194-201.
15. Yoshikawa N, Ito H, Nakamura H. Prognostic indicators in childhood IgA nephropathy. Nephron 1992;60:60-7.
16. Egido J, Blasco R, Sancho J, Lozano L. T cell dysfunction in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol 1983;26:201-12.
17. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Br Med J 1986;292:789-92.
18. Eddy AA, McCulloch L, Liu E, Adams J. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991; 138:1111-23.
19. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:1697-709.
20. Newman DJ, Thakkar H, Gallagher H. Progressive renal disease: Does the quality of the proteinuria matter or only the quantity? Clin Chim Acta 2000;297:43-54.
21. Lai KN, Lai FM, Li PK, Owen VJ. Cyclosporine treatment of IgA nephropathy: a short term of controlled trial. Br Med J 1987;295:1165-8.
22. Chabova V, Tesar V, Zabka J, Rychlik I, Merta M, Jirsa MJr, Stejskaova A. Long-term treatment of IgA nephropathy with cyclosporin A: a preliminary report. Nephrol Dial Transplant 1997;12:2206-7.
23. Shu KH, Ho WL, Lu YS, Cheng CH, Wu MJ, Lian JD. Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function. Clin Nephrol 1999; 52:5-9.